Clinical Trial: Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma
Brief Summary: The purpose of this study is to determine the safety of an injection of coxsackievirus A21 into a melanoma tumour, and also to see if there is a tumour response.
Detailed Summary: Coxsackievirus A21, a naturally occurring enterovirus, has shown that in vivo it can infect and lyse melanoma. This study is to assess safety of a single intratumoural injection of the virus into an accessible subcutaneous melanoma metastasis.
Sponsor: Viralytics
Current Primary Outcome: Safety profile of treatment, characterisation of adverse events
Original Primary Outcome: Same as current
Current Secondary Outcome: Efficacy - clinical response of injected and non-injected tumours
Original Secondary Outcome: Same as current
Information By: Viralytics
Dates:
Date Received: October 7, 2005
Date Started: August 2005
Date Completion:
Last Updated: May 9, 2017
Last Verified: May 2017